# OX Alpha task: round66_adjacent_art

- Timestamp: 2026-08-22T03:02:36.956934+00:00
- Model: stealth/ox-alpha
- Elapsed: 90.64s
- Finish reason: stop
- Usage: {"prompt_tokens": 2341, "completion_tokens": 2972, "total_tokens": 5313, "cost": 0, "is_byok": false, "prompt_tokens_details": {"cached_tokens": 64, "cache_write_tokens": 0, "audio_tokens": 0, "video_tokens": 0}, "cost_details": {"upstream_inference_cost": 0, "upstream_inference_prompt_cost": 0, "upstream_inference_completions_cost": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "image_tokens": 0, "audio_tokens": 0}}

## User prompt

```
You are performing the ADJACENT-SPEED-CONTROL §103 ASSESSMENT for Round 66. The CTO must decide: does the adjacent automated-speed-control prior art, combined with the forward-prediction concept, make the candidate's end-to-end loop obvious under §103?

CEO ROUND 65 AUDIT DIRECTIVE:
"Replace 'LEGAL GATE: PASS' with 'US11504151B2 velocity-language check: PASS; §103 gate: OPEN.' The distinction is essential. A patent need not use the word 'velocity' to disclose or support a controlled-retrieval concept. §103 is not defeated by showing that one patent lacks a keyword."

CEO-IDENTIFIED ADJACENT ART:
- 2025 'Thrombectomy Methods' applications: controlled slow-rate pulls, fast duty-cycled pulls, sensing at the tip, adjusting plunger speed based on live pressure feedback, automatic adjustment of pull rate.
- Sensors + controller that determines catheter-tip conditions and automatically controls plunger location and extraction flow rate.
- Current thrombectomy apparatus family: sensor-driven control of extraction, including mechanical extraction and aspiration responses.
- Experimental thrombectomy work uses automated retrieval at fixed 2 mm/s while measuring traction force; other work uses 5 mm/s with force at 2000 Hz.

============================================================
ADJACENT-SPEED-CONTROL SEARCH RESULTS (Round 66)
============================================================

10 patent hits + 32 non-patent hits identified across 10 queries. 3 most concerning patents fetched with actual claims:

EP3806757B1 — "Apparatus and methods for controlled clot aspiration":
- Claims teach: sensing unit (differential pressure sensors, magnetic/acoustic/optical/thermal flow sensors) configured to detect flow + produce signal; controller configured to AUTOMATICALLY CLOSE valve to stop flow when signal indicates unrestricted flow.
- This is SENSOR → CONTROLLER → AUTOMATIC FLOW-RATE MODULATION in thrombectomy.
- 45 'flow' occurrences in claims, 30 'control', 13 'sensor', 8 'pressure', 4 'automatic'.
- KEY CLAIM LANGUAGE: "a sensing unit configured to detect flow within the connecting tube and to produce a signal representative of such flow; and a controller... configured to automatically close the valve to stop flow through the connecting tube when the signal indicates unrestricted [flow]."

US11096712B2 — "Aspiration thrombectomy system":
- Claims teach: controllable vacuum valve + controllable vent valve; controller cyclically opens/closes valves to change pressure levels and control flow.
- 16 'control', 3 'flow', 2 'pressure'. This is valve-cycling pressure/flow control, NOT traction-speed modulation.

EP3823686B1 — "Aspiration thrombectomy system":
- Similar to US11096712B2 — controllable vacuum/vent valves, cyclic operation, pressure/flow control.
- NOT traction-speed modulation.

ADDITIONAL NON-PATENT HITS (competitive/literature frontier):
- Rapidpulse: "algorithms of the system's controller are acting on real time data, such as static pressure" — real-time controller acting on sensor data.
- Thrombectomy Catheter Pressure Control (Patsnap): "Machine learning detects clot engagement and switches catheter aspiration pressure to improve thrombectomy" — ML→detection→actuation.
- CN122376206A (2026): "When the algorithm detects blockage, it can cause the system to generate various pressure pulses with aspiration cycles" — algorithm→detection→actuation (claims not fetched; blocked by Google Patents).

============================================================
YOUR ASSESSMENT — produce these sections:
============================================================

SECTION 1: DOES ADJACENT ART TEACH SENSOR → CONTROLLER → EXTRACTION-RATE/FLOW MODULATION?

Answer definitively:
- Does EP3806757B1 teach sensor → controller → automatic flow-rate modulation in thrombectomy? YES / NO — quote claim language.
- Does this constitute "automated extraction-speed control" as the CEO described?
- Is FLOW-RATE modulation the same as TRACTION-VELOCITY modulation? (Different actuators: flow rate = aspiration; traction velocity = pull speed. But both are "extraction rate" in a broad sense.)
- Does the adjacent art, individually or in combination, teach the FULL loop: sensor → forward prediction → pre-event intervention? YES / NO / PARTIAL.

SECTION 2: §103 OBVIOUSNESS — COMBINATION ATTACK

The CEO's core question: "Would combining the known control architecture (sensor → controller → extraction-rate modulation) with the proposed forward-prediction signal be an obvious design move?"

Assess:
- Is it obvious to add forward prediction to EP3806757B1's sensor→controller→flow-control architecture?
- What would be needed to make the combination obvious? (new sensor? new algorithm? new motivation?)
- Is there motivation in the prior art to add prediction (rather than just reactive control)?
- Is the candidate's loop (sensor → friability index → FORWARD PREDICTION → traction-VELOCITY modulation → reduced embolization) reconstructable from: EP3806757B1 (sensor→controller→flow) + US11504151B2 (pull force) + US20250186070A1 (clot characterization) + general closed-loop control?

SECTION 3: FORCE-vs-FLOW-vs-VELOCITY DISTINCTION REVISITED

The candidate's actuator is traction-VELOCITY (pull speed). The adjacent art teaches:
- FLOW-RATE modulation (EP3806757B1, US11096712B2, EP3823686B1 — aspiration flow control via valves)
- FORCE maintenance (US11504151B2 — pull force in target range)
- PRESSURE modulation (Rapidpulse — pulsed vacuum pressure)

Is traction-VELOCITY modulation still genuinely distinct from FLOW-RATE and PRESSURE modulation? Or is the distinction collapsing under §103 combination pressure?

Assess honestly:
- Are flow-rate, pressure, and velocity all "extraction rate" in a broad sense that a POSITA would find interchangeable?
- Or are they genuinely different actuators with different physics?
- Does the candidate's claim survive only if it recites velocity specifically tied to a fragmentation-PREDICTION signal (not just generic extraction control)?

SECTION 4: DOWNGRADED LEGAL CONCLUSION

Per CEO directive, the legal conclusion must be downgraded. State the corrected conclusion:
- US11504151B2 velocity-language check: PASS (no velocity keyword found)
- §103 gate: OPEN (adjacent art teaches sensor→controller→extraction-rate/flow modulation; combination with forward prediction may be obvious)
- The candidate's legal novelty is NOT established. It depends on whether forward prediction + traction-velocity specifically (not generic extraction control) survives §103.

SECTION 5: PHYSICS GATE PRE-REGISTRATION

Per CEO directive, pre-register the physics gate kill conditions:
1. Median lead time <1s → KILL
2. High false-positive rate at clinically acceptable sensitivity → KILL
3. Precursor disappears under realistic flow/curvature → KILL
4. Signal varies primarily with device motion rather than clot state → KILL
5. Intervention cannot execute before fragmentation → KILL
6. Predicted intervention fails to reduce embolization → KILL

For each: state what the experiment must measure to test the condition.

SECTION 6: FINAL VERDICT

- KILL: The adjacent art makes the candidate obvious under §103. Record CE-019. Slot 5 EMPTY.
- CONDITIONAL SURVIVAL — PHYSICS GATE BLOCKED: Legal novelty not established (§103 OPEN), but the candidate lives or dies on whether forward prediction is physically real. The physics gate is the decisive test.
- PROMOTE: Not warranted.

Do NOT make the strategic decision — the CTO decides. State the engineering case.

CONSTRAINTS:
- Be adversarial. Try to find that the combination is obvious.
- Do NOT use force/flow/velocity distinctions as semantic loopholes if they are not genuine (CE-012).
- Quote actual claim language from EP3806757B1.
- Mark INCONCLUSIVE where evidence is insufficient.

Target ~2000-2500 words.

```

## Response (content)

ADJACENT-SPEED-CONTROL §103 ASSESSMENT — ROUND 66

============================================================
SECTION 1: DOES ADJACENT ART TEACH SENSOR → CONTROLLER → EXTRACTION-RATE/FLOW MODULATION?
============================================================

1.1 EP3806757B1 — YES.

Claim language (as fetched in Round 66): "a sensing unit configured to detect flow within the connecting tube and to produce a signal representative of such flow; and a controller... configured to automatically close the valve to stop flow through the connecting tube when the signal indicates unrestricted [flow]."

This is a complete sensor → controller → automatic flow-rate modulation loop inside thrombectomy. The sensing unit is broad ("differential pressure sensors, magnetic/acoustic/optical/thermal flow sensors"), and the controller actuates flow automatically on the sensed signal. Term-frequency profile (45 'flow', 30 'control', 13 'sensor', 8 'pressure', 4 'automatic') confirms this is the patent's core teaching, not incidental.

1.2 Does this constitute "automated extraction-speed control" as the CEO described?

PARTIAL. It constitutes automated EXTRACTION-RATE control in the aspiration sense: the controller modulates how fast blood/clot material is extracted (flow rate, down to zero via valve closure). It does NOT modulate mechanical pull speed of a captured thrombus. The CEO's framing — "a patent need not use the word 'velocity' to disclose or support a controlled-retrieval concept" — is correct as to the concept of automated extraction control generally, but EP3806757B1's controlled quantity is volumetric flow, not traction kinematics.

1.3 Is FLOW-RATE modulation the same as TRACTION-VELOCITY modulation?

NO — they are different actuators with different physics:

- Flow rate: governed by pressure differential, catheter/tube conductance, clot permeability; actuator is a vacuum source/valve.
- Traction velocity: governed by displacement of a capture element relative to the vessel wall; actuator is a drive mechanism; force and velocity are coupled through clot-bond mechanics.

However, both are "extraction rate" at the functional level of "how quickly thrombus leaves the vessel." A POSITA reading the claims functionally would see both as instances of closed-loop extraction control. The distinction is real at the physics level but is NOT a safe harbor at the claim-construction level if the candidate's claims are drafted functionally. This is the CE-012 trap: do not lean on the velocity/flow vocabulary difference as if it were a legal wall.

1.4 Does the adjacent art teach the FULL loop: sensor → forward prediction → pre-event intervention?

NO. It teaches PARTIAL:

- Sensor → controller → reactive intervention: TAUGHT (EP3806757B1 explicitly; US11096712B2/EP3823686B1 valve cycling; Rapidpulse real-time pressure-driven algorithms; CN122376206A algorithm-detects-blockage → pressure pulses).
- Forward prediction (anticipating fragmentation BEFORE it occurs from a friability/precursor index): NOT taught by any fetched reference. All identified loops are REACTIVE — they respond to a detected present state (unrestricted flow, blockage, pressure excursion). None projects a future event.
- Traction-velocity modulation specifically: NOT taught. US11504151B2 teaches pull-force maintenance (force in target range), which implies speed adjustment as a means but does not claim or teach velocity as the controlled variable tied to a fragmentation-prediction signal.

Verdict: PARTIAL. The architecture is taught; the predictive element and the specific actuator are not.

============================================================
SECTION 2: §103 OBVIOUSNESS — COMBINATION ATTACK
============================================================

2.1 Is it obvious to add forward prediction to EP3806757B1's architecture?

The adversarial answer: a §103 examiner would argue YES, for these reasons:

(a) The architecture (sensor → controller → automatic modulation) is admitted prior art in thrombectomy. Adding a predictive layer to an existing closed-loop controller is a textbook control-engineering improvement — feedforward/predictive control is standard practice wherever a plant has latency between detection and adverse outcome.

(b) Motivation exists in the art itself: embolization during thrombectomy is a known failure mode; CN122376206A already uses an algorithm to detect blockage and pre-shape aspiration cycles (pulses), i.e., anticipatory shaping of actuation based on inference rather than raw threshold crossing. That is one step from prediction.

(c) US20250186070A1 (clot characterization) supplies the "what to predict from"; US11504151B2 supplies traction-force sensing during retrieval; general closed-loop control supplies the predictive-controller template. The combination requires no new sensor hardware — only software.

2.2 What would be needed to make the combination obvious vs. non-obvious?

To make it obvious, a POSITA needs only: (i) recognition that fragmentation causes embolization (known clinical problem), (ii) a measurable precursor (supplied by clot-characterization art), (iii) a standard predictive controller. If all three are found in cited art, the combination is likely obvious UNLESS the specific precursor signal or the velocity-specific actuation produces unexpected results.

To survive, the candidate must show at least one of:
- The precursor signal itself is novel and non-obvious (not derivable from existing clot-characterization measurements);
- Traction-velocity (rather than flow/pressure) is the uniquely effective actuator for preventing fragmentation — i.e., the choice of actuator is not interchangeable, defeating the obvious-substitution attack;
- Unexpected results: quantified embolization reduction attributable to prediction + velocity modulation that reactive control cannot achieve.

2.3 Is there motivation to add prediction rather than reactive control?

YES, inferentially. Reactive control has inherent latency: by the time unrestricted-flow or force-excursion is detected, fragmentation may have occurred. A POSITA facing embolization-as-failure-mode has an engineering motivation to move detection earlier in time. This motivation is generic, however — it motivates "predict something bad," not "predict fragmentation from THIS specific precursor." The specific precursor remains the candidate's potential non-obvious contribution.

2.4 Reconstructability test.

Candidate loop = EP3806757B1 (sensor→controller→flow) + US11504151B2 (pull-force sensing) + US20250186070A1 (clot characterization) + general predictive control.

Reconstruction result:
- Sensor → index → controller → actuation: reconstructable.
- FORWARD PREDICTION step: not literally in any reference; must be supplied by "general closed-loop control" knowledge. Under KSR-style reasoning, supplying a known technique (prediction) from another field to improve a known system (thrombectomy control) with a known problem (embolization) is the classic obviousness pattern.
- TRACTION-VELOCITY as actuator: substitutable-attack surface. An examiner will argue flow-rate reduction achieves the same protective effect (less drag on clot) and is taught.

Honest conclusion: the combination attack is STRONG. The candidate's residual non-obviousness rests entirely on (a) the specific friability-precursor signal being non-obvious, and (b) velocity-specific actuation being shown non-interchangeable. Both are currently UNPROVEN — they are physics-gate questions, not legal ones.

============================================================
SECTION 3: FORCE-vs-FLOW-vs-VELOCITY DISTINCTION REVISITED
============================================================

3.1 Are they interchangeable "extraction rate"?

At the functional level, partially yes. All three modulate how fast thrombus is removed. A POSITA would regard them as alternative actuators in the same control space. CE-012 discipline: I will not treat the vocabulary difference as a defense.

3.2 Are they genuinely different actuators with different physics?

YES, genuinely:
- Flow/pressure act on the ASPIRATION side; their effect on a mechanically captured clot is indirect (drag, suction stress).
- Traction velocity acts directly on clot-bond loading rate. Fragmentation under tension is rate-dependent (viscoelastic/brittle fracture behavior); force-maintenance schemes (US11504151B2) implicitly modulate velocity but only reactively and without a fragmentation-prediction target.
- Critically: a force-maintenance controller and a velocity-modulation controller can produce identical trajectories in some regimes — meaning the candidate's velocity recitation may be treated as an obvious parameterization of known force control unless tied to the prediction signal.

3.3 Survival condition.

The candidate's claim survives ONLY IF it recites: traction-velocity modulation driven specifically by a forward-prediction signal derived from a friability/fragmentation precursor — not generic extraction control, not reactive force maintenance. Generic velocity claims die under the combination. Prediction-tied velocity claims face a genuine but narrower §103 question hinging on whether the precursor is non-obvious.

============================================================
SECTION 4: DOWNGRADED LEGAL CONCLUSION (per CEO directive)
============================================================

Corrected statement:

- US11504151B2 velocity-language check: PASS (no velocity keyword found).
- §103 gate: OPEN.
- Legal novelty is NOT established. Adjacent art (EP3806757B1 et al.) teaches sensor → controller → automatic extraction-rate modulation in thrombectomy. Combined with US11504151B2 (traction force), US20250186070A1 (clot characterization), and general predictive-control knowledge, the candidate's end-to-end loop is arguably obvious except for two unresolved elements: (1) the specific forward-prediction precursor, and (2) velocity-specific actuation tied to that prediction. Whether those elements save the claim is a question the current record cannot answer; it is gated on physics evidence, not further searching alone.

Strongest alternative explanation (Art. XXXII compliance): the candidate's apparent distinctiveness may be an artifact of query selection — we searched adjacent-speed-control terms and found flow/pressure controllers; a search using inventor vocabulary around "retrieval rate," "displacement control," "servo pull," or robotics-assisted vascular intervention might surface direct traction-velocity prior art. Status: INCONCLUSIVE — not searched this round.

============================================================
SECTION 5: PHYSICS GATE PRE-REGISTRATION
============================================================

Kill condition 1 — Median lead time <1s.
Measure: time delta between first statistically significant precursor crossing and observed fragmentation onset, across all fragmentation events in bench/ex-vivo trials. Report median and distribution. Kill if median <1s.

Kill condition 2 — High false-positive rate at clinically acceptable sensitivity.
Measure: ROC/PR curve of precursor-based predictor against ground-truth fragmentation labels; report sensitivity at fixed specificity (e.g., 90%) and FP/hour of operation. Kill if clinically acceptable sensitivity (define threshold pre-hoc, e.g., ≥80%) yields unacceptable FP burden (pre-register numeric threshold).

Kill condition 3 — Precursor disappears under realistic flow/curvature.
Measure: precursor detectability (SNR, effect size) across a matrix of physiological flow rates, vessel curvatures, and pulsatility in a realistic phantom. Kill if precursor effect becomes indistinguishable from noise in any dominant clinical-condition stratum.

Kill condition 4 — Signal varies primarily with device motion rather than clot state.
Measure: controlled factorial experiment varying device motion parameters (speed, jitter, operator input) with clot state held constant, and vice versa; variance decomposition / partial correlation of signal with motion vs. clot-state factors. Kill if motion explains the dominant share of signal variance.

Kill condition 5 — Intervention cannot execute before fragmentation.
Measure: end-to-end actuation latency (detection-to-deceleration) versus measured lead-time distribution from condition 1; compute P(intervention completes before predicted event). Kill if execution probability below pre-registered threshold (e.g., <80% of events).

Kill condition 6 — Predicted intervention fails to reduce embolization.
Measure: randomized paired comparison (prediction+velocity modulation vs. reactive-only vs. no control) in ex-vivo/bench model; primary endpoint distal embolic particle count/mass. Kill if no statistically significant reduction attributable to the predictive-velocity arm.

============================================================
SECTION 6: FINAL VERDICT (engineering case; CTO decides)
============================================================

CONDITIONAL SURVIVAL — PHYSICS GATE BLOCKED.

Engineering case summary:
- §103 gate is OPEN. The combination attack is strong: known architecture + known problem + generic motivation to predict + substitutable-actuator argument. The candidate's legal novelty is not established and should not be represented as established.
- Residual non-obviousness lives in exactly two places: the specific friability-precursor signal, and velocity-specific actuation tied to prediction. Both are empirical questions.
- Therefore the decisive test is the Section 5 physics gate, particularly conditions 1, 4, and 6 (lead time, motion-confound, embolization reduction). If the precursor is physically real, robust to motion confounds, and predictive-velocity modulation beats reactive control on embolization, the unexpected-results argument gives the claim a defensible path despite the OPEN §103 gate. If any kill condition fires, the candidate dies regardless of legal posture.
- PROMOTE is not warranted on the current record.

Open items flagged for CTO decision:
(a) Authorize a targeted follow-up search using inventor/robotics vocabulary for direct traction-velocity prior art before relying on its absence (Art. XXXII alternative explanation currently INCONCLUSIVE).
(b) Decide whether to proceed to physics-gate experiments given OPEN §103 risk, or hold pending the follow-up search.

References cited: EP3806757B1; US11096712B2; EP3823686B1; US11504151B2; US20250186070A1; CN122376206A (claims not fetched — INCONCLUSIVE); Rapidpulse public statements (no verifiable citation ID — UNKNOWN); experimental fixed-rate retrieval studies (citation IDs UNKNOWN from current record).

---

## Reasoning (for audit)

Produce structured assessment, ~2000 words, plain text.
